FDA Drug Application (040416) for JANTOVEN by USL PHARMA

Back to FDA Applications sponsored by USL PHARMA

Application Number040416
Product Number001
FormTABLET;ORAL
Dosage1MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameJANTOVEN
Active IngredientWARFARIN SODIUM

Active IngredientCount
List of drugs with Active Ingredient WARFARIN SODIUM5


Back to FDA Applications sponsored by USL PHARMA